Institute of Science Tokyo · Institute for Advanced Studies · 教授

Research keywordsmedicinal chemistry・薬品化学・Stereochemistry・Combinatorial・chemistry・Biochemistry・Peptide・3

Research fieldsDrug development chemistry・Pharmacy・Virology・Chemical pharmacy・Medicine・Medicine, Dentistry, and Pharmacy・医薬分子機能学・Basic medicine

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Tsuji K, Bai K, Huang X, Tamamura H. Affinity enhancement of polo-like kinase 1 polo-box domain-binding peptides by N-methylation and lipidation. Organic & biomolecular chemistry. 2026.03; 24 (14): 3031-3039. ( PubMed , DOI )2026
• Tsuji K, Miura Y, Kuwata T, Matsuzaki R, Kobayakawa T, Matsumoto K, Ito Y, Yoshiya T, Matsushita S, Tamamura H. CD4 Mimic-Neutralizing Antibody Conjugates Synthesized by Site-Specific Modification Methods as HIV-1 Entry Inhibitors. ChemMedChem. 2026.02; 21 (3): e202500820. ( PubMed , DOI )2026
• 辻 耕平. 二価型阻害剤戦略に基づくがん関連キナーゼを標的とした中分子創薬研究 薬学雑誌. 2025.10; 145 (10): 815-821. ( 医中誌 )2025
• Shinohara K, Kobayakawa T, Tsuji K, Takamatsu Y, Mitsuya H, Tamamura H. SARS-CoV‑2 Papain-Like Protease Inhibitors Based on Naphthalen-1-ylethanamine and Halogenated Benzene Moieties. ACS omega. 2025.10; 10 (40): 47165-47175. ( PubMed , DOI )2025

• Structure-activity relationships in peptides
• ペプチドの構造活性相関研究
• 抗がん剤、抗エイズ薬,抗アルツハイマー薬の創製
• anti-cancer drug, anti-HIV drug,β-secretase inhibitors

• Official profile
• KAKEN
• CiNii